Are you interested in participating in a study by Asymmetrex to evaluate the current state of knowledge on the changing stem cell medicine landscape? If so, please, visit: http://bit.ly/SCcountquiz
The landscape of stem cell medicine is changing, and it’s all about counting. There is growing awareness of the long-standing unmet need for specific counting of therapeutic tissue stem cells. This year, the FDA’s Standards Coordinating Body (SCB) listed determination of tissue stem cell-specific dose as a priority for standards development for stem cell clinical trials.